CA
NZ
UK
AU
IND
US
November brought heightened volatility across the technology sector, with concerns surrounding the pace of innovation and the sustainability of valuations. Even though D-Wave Quantum (NYSE:QBTS) is not directly tied to theartificial intelligenceboom, it was still affected by a shift in investor sentiment toward early-stage …
Wave Life Sciences (NASDAQ:WVE) made headlines on Monday after announcing interim results from a Phase 1 clinical trial of its investigational weight loss drug, WVE-007. The drug demonstrated a 4.5% reduction in total body fat over three months, compared to no meaningful change in …
News Corporation’s (NASDAQ:NWSA) stock closed lower on Monday, slipping 30.50 cents, or 1.2%, to end at$25.73. The decline contrasted with the broader market’s move, as theNASDAQ-100 Index dipped 0.2%, placing NWSA’s relative change at–0.9%for the session.
In its latest investor note, Citigroup downgraded Salesforce (NYSE:CRM) from a “strong-buy” rating to “hold,” as reported by Zacks.com. The move reflects evolving assessments of the company’s near-term prospects following its recent earnings release. Citigroup’s change adds to a broader pattern of re-evaluation across …
Market Movers (Yesterday):Capricor Therapeutics, Inc. surged 371.07%, leading the gainers, followed by iRobot Corporation which jumped 73.85%. Acrivon Therapeutics and several other small-cap biotech names also rallied sharply on short covering and FDA-driven optimism. On the downside, WORK Medical Technology Group Ltd fell 35.94%, …
Victoria’s Secret & Co. (NYSE:VSCO) released its earnings results on Friday. The company reportedEPSof (USD 0.27)for the quarter, which was above the consensus estimate of(USD 0.60). Revenue for the period came in atUSD 1.47 billion, compared with analysts’ expectations ofUSD 1.41 billion. Return on …
Ceva, Inc. (NASDAQ:CEVA) currently holds a“Moderate Buy”consensus rating from six research firms that cover the stock. Marketbeat Ratings notes thatone firm issued a sell recommendation, whilefive firms issued buy recommendations. These firms updated their coverage during the past year. Theaverage 12-month target priceamong analysts …
MarketBeat Ratings reports thatargenx SE (NASDAQ:ARGX)holds anaverage rating of “Moderate Buy.”This assessment comes fromtwenty-four brokeragescurrently following the biotechnology company. Of these:
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) closed atUSD 16.07on December 05, reflecting a rise of17.0c (1.1%)from the prior session. The move compared with theNASDAQ-100, which added85.5 points (0.3%)during the day. The stock’s relative price increase of0.7%against the index placed it ahead of the broader benchmark …
As the trading week wrapped up, the tech-drivenNasdaq 100showcased firm resilience, shrugging off recent turbulence and closing on an optimistic note. With a key inflation reading finally released, traders set aside political noise and lingering macro uncertainty, redirecting their full attention to the Federal …
Please wait processing your request...